Bristol-Myers Squibb Japan

Last update: August 28, 2019

Pharmaceuticals
Japan Its 3 main executives

Recent executive movements at Bristol-Myers Squibb

Nadim Ahmed who was President, Hematology and Oncology, Celgene, becomes President, Hematology  (news posted on November 21 2019).
David Elkins, who was Executive Vice President and Chief Financial Officer, Celgene, is promoted to Executive Vice President and Chief Financial Officer  (news posted on November 21 2019).
Phyllis Yale will join the company as Director in Dec. 2019  (news posted on November 21 2019).

Click here to view some more movements at Bristol-Myers Squibb

Create an alert
to follow the executive moves at Bristol-Myers Squibb Japan.

Latest M&A news in Pharmaceuticals.

Novartis has announced the acquisition of Medicines (posted on Nov 27, 2019).
Glaukos has acquired Avedro (posted on Nov 22, 2019).
Bristol-Myers Squibb has acquired Celgene (posted on Nov 21, 2019).

Latest news about Bristol-Myers Squibb Japan

Bristol-Myers Squibb Japan on Wikipedia, Google News & Yahoo Finance

Bristol-Myers Squibb Japan on LinkedIn, Twitter & YouTube

Bristol-Myers Squibb Japan has 1,958 competitors including Johnson & Johnson (United States (USA)), Roche (Switzerland) and Pfizer (United States (USA)). Bristol-Myers Squibb Japan is owned by Bristol-Myers Squibb APAC.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.